United4Rare is a mission-driven, for-profit consulting and medtech company dedicated to transforming the rare disease landscape. With over 45 years of combined experience, we specialize in connecting clinical innovation with the real needs of rare disease patients.

Our work is built on decades of advocacy leadership, policy success, and direct patient support, now paired with innovative medtech solutions such as CortiCheck™, our real-time adrenal health monitor. With a proven track record of patient advocacy and enrollment strategy for clinical trials, we serve as the liaison between trial sponsors, clinical teams, and patients, ensuring clear communication, trust, and accessibility. By bridging these worlds, we help clinical trials meet their enrollment goals while ensuring patients feel informed, supported, and empowered to participate.

For investors and collaborators, United4Rare offers a rare combination of credibility, access, and innovation. For nonprofits and clinicians, we provide the expertise to navigate the complex realities of rare disease engagement, accelerate recruitment, and strengthen relationships with the communities they serve. Together, we can advance the rare disease field with precision, compassion, and the patient’s voice at the center of every solution.

Our flagship product, CortiCheck, is a first of its kind handheld cortisol rapid blood test monitor that will revolutionize the way Adrenal Insufficiency is diagnosed and treated. From at-home use to the ER, this will change thousands of lives and provide a more secure future for patients and families while also steering research.